Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,971 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Putting seedlings on the map: Trade-offs in demographic rates between ontogenetic size classes in five tropical forests.
Kambach S, Bruelheide H, Comita LS, Condit R, Wright SJ, Aguilar S, Chang-Yang CH, Chen YY, Garwood NC, Hubbell SP, Luo PJ, Metz MR, Nasardin MB, Pérez R, Queenborough SA, Sun IF, Swenson NG, Thompson J, Uriarte M, Valencia R, Yao TL, Zimmerman JK, Rüger N. Kambach S, et al. Among authors: perez r. Ecology. 2025 Jan;106(1):e4527. doi: 10.1002/ecy.4527. Ecology. 2025. PMID: 39844593
Real-World Experience in Tricuspid Transcatheter Edge-to-Edge Repair: Transcatheter Tricuspid Valve Repair in Spain Registry.
Sisinni A, Barreiro-Perez M, Freixa X, Arzamendi D, Moñivas V, Carrasco-Chinchilla F, Pan M, Nombela-Franco L, Pascual I, Benito-González T, Perez R, Gómez-Blázquez I, Amat-Santos IJ, Cruz-González I, Sánchez-Recalde Á, Alvarez ABC, Sanchis L, Caneiro-Queija B, Li CH, Del Trigo M, Martínez-Carmona JD, Mesa D, Pozo E, Avanzas P, Cepas-Guillén P, Estévez-Loureiro R. Sisinni A, et al. Among authors: perez r. J Am Heart Assoc. 2025 Jan 21;14(2):e037070. doi: 10.1161/JAHA.124.037070. Epub 2025 Jan 17. J Am Heart Assoc. 2025. PMID: 39818971 Free article.
Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study.
Sangro B, Kudo M, Erinjeri JP, Qin S, Ren Z, Chan SL, Arai Y, Heo J, Mai A, Escobar J, Lopez Chuken YA, Yoon JH, Tak WY, Breder VV, Suttichaimongkol T, Bouattour M, Lin SM, Peron JM, Nguyen QT, Yan L, Chiu CF, Santos FA, Veluvolu A, Thungappa SC, Matos M, Żotkiewicz M, Udoye SI, Kurland JF, Cohen GJ, Lencioni R; EMERALD-1 Investigators. Sangro B, et al. Lancet. 2025 Jan 18;405(10474):216-232. doi: 10.1016/S0140-6736(24)02551-0. Epub 2025 Jan 8. Lancet. 2025. PMID: 39798579 Clinical Trial.
2,971 results